Shanghai RAAS Blood Products Co., Ltd. (SHE:002252)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Production and Sale of Blood Products	8.18B	7.96B	6.57B	4.29B	2.76B
Production and Sale of Blood Products Growth	2.67%	21.27%	53.16%	55.31%	6.81%
Unallocated Other Operations	-	-	-	-	994.92K
Unallocated Other Operations Growth	-	-	-	-	323.79%
Total	8.18B	7.96B	6.57B	4.29B	2.76B
Total Growth	2.67%	21.27%	53.16%	55.26%	6.84%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
East China	2.99B	2.98B	2.41B	1.54B	998.73M
East China Growth	0.41%	23.53%	56.41%	54.31%	5.29%
Southern China	1.69B	1.86B	1.59B	1.03B	652.64M
Southern China Growth	-8.96%	16.35%	54.14%	58.53%	-0.53%
Northern China	2.10B	1.93B	1.54B	897.27M	682.55M
Northern China Growth	8.90%	25.44%	71.45%	31.46%	20.72%
Northeast China Region	384.13M	298.30M	251.66M	172.13M	87.75M
Northeast China Region Growth	28.77%	18.53%	46.20%	96.15%	-5.12%
Southwest Region	484.42M	516.08M	323.00M	202.02M	190.55M
Southwest Region Growth	-6.13%	59.78%	59.89%	6.02%	-11.81%
Northwestern Region	470.48M	363.76M	279.67M	167.32M	54.62M
Northwestern Region Growth	29.34%	30.07%	67.14%	206.31%	21.78%
Export	56.69M	22.81M	169.23M	273.16M	94.84M
Export Growth	148.56%	-86.52%	-38.05%	188.03%	54.17%
Total	8.18B	7.96B	6.57B	4.29B	2.76B
Total Growth	2.67%	21.27%	53.16%	55.26%	6.84%

Source: S&P Global Market Intelligence.